Arrowhead Pharmaceuticals's chart data is dated 2026-10-09. Recorded technical signals: RSI rebound, MACD bullish cross. There are 5 published signal records.
Arrowhead Pharmaceuticals last closed at $62.75 (+3.31%) on 2026-10-09. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -27.2×. Its overall grade ranks 407 of 738 stocks in Healthcare.
About this company
Arrowhead Pharmaceuticals last closed at $62.75 (+3.31%) on 2026-10-09. Signals today: RSI rebound, MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B- · 407/738
Valuation grade B+
Related stocks
- AmgenCompetitor
RNA 치료제·희귀질환/염증 분야에서 경쟁하는 대형 바이오기업
- Alnylam PharmaceuticalsCompetitor
RNAi 치료제 플랫폼의 대표 경쟁사
- Ionis PharmaceuticalsCompetitor
핵산 기반 치료제 개발에서 경쟁하는 기업
ETFs holding this stock
Adaptiv Select ETF · iShares Neuroscience and Healthcare ETF · Alger Mid Cap 40 ETF
Details →About Arrowhead Pharmaceuticals
- What technical signals does Arrowhead Pharmaceuticals (ARWR) have?
- Arrowhead Pharmaceuticals current technical signals: RSI rebound, MACD bullish cross.
- Is Arrowhead Pharmaceuticals a cup-and-handle pattern?
- No. Arrowhead Pharmaceuticals has no valid Cup signal right now.
- What published figures are available for Arrowhead Pharmaceuticals?
- Market cap: $8.52B. Trailing 12 months PER: -27.2×. Latest quarter PBR: 18.69×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-09 dataset
Turn what you saw on this name into a strategy
Ask Q about Arrowhead Pharmaceuticals, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.